3/31/2017 OBJECTIVES CASE STUDY #1 MANUAL REVIEW. Hematology Case Studies: Every Picture Tells a Story
|
|
- Mae Sharp
- 6 years ago
- Views:
Transcription
1 OBJECTIVES Hematology Case Studies: Every Picture Tells a Story Jason Anderson, MPH, MT(ASCP) Field Product Specialist Discuss how scattergram and histogram pictures can provide insight into abnormal hematology samples Utilize case studies to demonstrate how enhanced technologies can benefit the patient and clinician, as well as enhance efficiency in your hematology workflow. CASE STUDY #1 CBC results post transfusion of 2 units packed RBCs A 59 y/o male patient presents to the E.R. with a complaint of increasing weakness, shortness of breath, headache and recent onset of dark-colored urine. The initial CBC result indicates that patient has severe anemia of unknown etiology. Patient is admitted and transfused with 2 units of packed RBCs. The following CBC result is 24 hours post transfusion. What issues do you see with the results? MANUAL REVIEW What do you see? Schistocytes Manual PLT Estimate= 21 Dx: Idiopathic Autoimmune Hemolytic Anemia 1
2 3/31/2017 W DF CHANNEL SCATTERGRAM - NORMAL PATTERN Mono Metas + Myelos + Pros IG Neut + Baso WDF Channel Lymph EO Debris Copyright 2012 by Sysmex America, Inc. All rights reserved. SIGNIFICANCE OF LEFT SHIFT? W DF CHANNEL WDF Channel IP Messages WBC Flags WBC Abn Scattergram Neutropenia Neutrophilia Lymphopenia Lymphocytosis Monocytosis Eosinophilia IG Present Blasts/Abn Lympho? Left Shift? Atypical Lympho? RBC Flags- None PLT Flags - PLT Clum Atypical Lymph Blast IG Abnormal Lymph BlastsMONO LYMPH NRBC Debris Left Shift NEUT+BASO EO Appearance pattern on Abnormal WDF LEFT SHIFT FLAG W HY BAN THE BAND?..The clinical folklore of the band persists despite little mention of its diagnostic utility in current textbooks. Textbooks in internal medicine, hematology, and laboratory medicine do NOT recommend band counts for the diagnosis of infection, other than to mention that neutrophilia and left-shift typically accompany infection or inflammation. Cornbleet, PJ., Clinical Utility of the Band Count. Clinics in Laboratory Medicine :1,
3 IG% & IG# REPORTABLE ON EVERY DIFF INCREASED IG COUNT; POSITIVE SAMPLE IG =27% INCREASED IG COUNT: POSITIVE SAMPLE Manual Diff Neutrophils: 16% Bands: 21% Lymphs: 19% Monocytes: 12% Eosinophils: 1% Metamyelocytes: 4% Myelocytes: 12% Promyelocytes: 11% Blasts: 11% IMMATURE GRANULOCYTES DIAGNOSTIC PERFORMANCE TO PREDICT INFECTION ROC characteristic to compare the ability of the parameters to predict infection Absolute IG (IG#) showed the highest sensitivity (89.2%) and specificity (76.4%) to detect infections (N=70) XN IG = 23.4% Nierhaus, A., et al. Revisiting the white blood cell count: immature granulocyte count as a diagnostic marker to discriminate between SIRS and sepsis a prospective, observational study. BMC Immunology :8 CASE STUDY #2 A 71 y/o female presents to her family practitioner with increasing concerns of persistent fatigue, diffuse pain in her chest and back and more bruising than normal. She also states that she has experienced recurring sinus and respiratory infections over the past 6 months. Upon examination, the patient was found to have an enlarged liver. Chemistry testing was unremarkable aside from a moderately elevated serum Calcium, Creatinine and Microalbumin level. Following is the initial CBC results What concerns do you see 3
4 DI60 IMAGES CASE STUDY #2 DIAGNOSIS? CASE STUDY #3 Plasma Cell Leukemia (PCL) Primary PCL is rare (1 in 1 million population). Secondary PCL affects ~ 4 out of a 100 Multiple Myeloma patients. 1.5x more common in men than in women The causes of PCL are not fully known, but risk factors such as age and exposure to industrial and environmental elements are thought to play important roles. Current treatments for PCL are the same as those for Multiple Myeloma and include chemotherapy drugs, Proteasome inhibitors, steroids and in younger and healthier patients, stem cell transplantation is an option. A 67 y/o male presented to his family physician for a routine wellness check. The patient states that he has experienced moderate unexplained weight loss and feels more run down than usual. Physical examination reveals swollen lymph nodes and mild bruising on extremities. Following is the initial CBC results What concerns do you see 4
5 CASE STUDY #3 DIAGNOSIS? Hairy Cell Leukemia (HCL) HCL is a chronic leukemia where the bone marrow produces a surplus of B-lymphocytes, which often present with hair-like, irregular cytoplasmic projections. Relatively rare disorder, but one of the most successfully treated of all leukemias (median remission of 15 years). HCL is a very indolent disease. Progression is slow and may not be diagnosed after several months or even years of illness. Front-line treatment agents for HCL are Pentostatin and Cladribine. WNR CHANNEL Scattergram - Normal Pattern FSC BASO NRBC Debris SFL WBC CASE STUDY #4 A 66 y/o male presents to his family practitioner for a routine check-up. During the examination, the patient states he is feeling generally ok, but when questioned further admits a recent history of : Weakness Fatigue Extreme night sweats Moderate weight loss Following is the initial CBC results What concerns do you see? 5
6 INCREASED BASOPHIL COUNT CASE STUDY #4 DIAGNOSIS? Chronic Myelogenous Leukemia (CML) ~ 1 person in 555 will get CML in their lifetime Occurs mainly in adults Slightly more common in men than in women Most cases of CML start when a "swapping" of chromosomal material (DNA) occurs between chromosomes 9 and 22. This translocation gives rise to a chromosome 22 that is shorter than normal (Philadelphia Chromosome). The swapping of DNA between the chromosomes leads to the formation of an oncogene called BCR-ABL. This gene then produces the BCR-ABL protein, which is the type of protein called a tyrosine kinase. This protein causes CML cells to grow and reproduce out of control. CASE STUDY #3 CML is classified into 3 groups or phases that help predict prognosis. These phases are based mainly on the number of myeloblasts that are seen in the blood or bone marrow. Chronic phase Less than 10% blasts in their blood or bone marrow. Patients usually have fairly mild symptoms (if any). Most patients are diagnosed in the chronic phase. CASE STUDY #3 Accelerated phase Patients are considered to be in accelerated phase if any of the following are true: The bone marrow or blood samples have more than 10% but fewer than 20% blasts High blood basophil count (basophils making up at least 20% of the white blood cells) High white blood cell counts that do not go down with treatment Very high or very low platelet counts that are not caused by treatment Blast phase (also called acute phase or blast crisis) BM and/or blood samples have more than 20% blasts. The blast cells often spread to tissues and organs beyond the bone marrow. PLATELET MEASUREMENT FSC RBC IPF PLT-F Channel PLT-F Impedance Platelet SFL Fluorescent Platelet Copyright 2012 by Sysmex America, Inc. All rights reserved. 6
7 INTERFERENCES IN IMPEDANCE PLATELET COUNTING Falsely Increased RBC fragments Microcytes Bacteria Immune complexes Falsely Decreased Giant platelets Platelet clumps CASE STUDY : OB PATIENT WITH GIANT PLATELETS Giant platelets in pregnant patients can be a normal phenomenon. Low platelet count complicates decision of placing a labor epidural due to risk of spinal hematoma. (plt cut-offs vary by institution). The problem with this is the failure of impedance technology to accurately recover a reportable number resulting in the technologist needing to manually intervene, which could prolong time to epidural decision. WBC fragments MICROSCOPIC IMAGES OF SLIDE OB PATIENT WITH GIANT PLATELETS Doc. No CFL, Rev 1, June 2014 Doc. No CFL, Rev 1, June 2014 Manual PLT Estimate= 141,000 CASE STUDY : CF PATIENT PLT Abnormal Distribution Patient is a newborn male with Down Syndrome and Cystic Fibrosis. Patient presented with decreased Platelet count. 7
8 Reflex PLT-F PLT MEASUREMENT OVER TIME IN A SEVERE BURN INJURY PATIENT PLT COUNT OVER TIME IN A BURN PATIENT PLT COUNT OVER TIME IN A BURN PATIENT PLT-F PLT-I Day 3 PLT-F PLT-I Day 2 PLT-F PLT-I Day 4 PLT-F PLT-I POSSIBLE MECHANISMS OF THROMBOCYTOPENIA DIFFERENTIATE PHYSIOLOGICAL MECHANISMS Production Disorders Myeloablative Therapy Bone Marrow Transplant Acute Myeloid Leukemia (AML) Destruction Disorders Immune Thrombocytopenic Purpura (ITP) Thrombotic Thrombocytopenic Purpura (TTP) Infections (HIV, Hepatitis C, CMV) Disseminated Intravascular Hemolysis (DIC) Autoimmune Disease Bacteremia Heparin Induced Thrombocytopenia (HIT) Sepsis Pregnancy Drug-Induced Thrombocytopenia (DIT) Low PLT + Normal/Low IPF (Consistent with production disorder) Normal Low PLT+ High IPF (Consistent with destruction disorders) Stasi, R. How to approach thrombocytopenia. Hematology :191; /asheducation
9 IPF CASE STUDY 48 YEAR OLD MALE WITH PANCREATIC CANCER CBC Cycle 1 Cycle 3 Cycle 3 Day 8 Units Normal Range WBC Low X10^3µl 4-11 RBC Low 3.97 Low X10^6µl HgB 13.1 Low 12.1 Low 10.9 Low g/dl HCT 36.3 Low 30.6 Low % PLT Low 42 Low X10^3µl IPF 0.0 Low % IPF CASE STUDY 48 YEAR OLD MALE WITH PANCREATIC CANCER CBC Cycle 1 Cycle 3 Cycle 3 Day 8 Next Day WBC Low X10^3µl 4-11 Units Normal Range RBC Low 3.97 Low X10^6µl HgB 13.1 Low 12.1 Low 10.9 Low g/dl HCT 36.3 Low 30.6 Low % PLT Low 42 Low 6 Low X10^3µl IPF 0.0 Low 0.0 Low % Value of IPF Relevant data that may contribute to treatment decisions Results can be obtained quickly without additional drain on resources Minimal cost and no discomfort compared to invasive diagnostic testing The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Cancer and Hematology of Western Michigan. The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Cancer and Hematology of Western Michigan. IPF CASE STUDY 59 YEAR OLD FEMALE WITH STAGE IV METASTATIC BREAST CANCER CBC Cycle 1 Cycle 3 Cycle 3 Day 8 Units Normal Range WBC Low 2.1 Low X10^3µl 4-11 RBC Low 2.99 Low X10^6µl HgB Low 10.6 Low g/dl HCT Low 31.1 Low % PLT Low 17 Low X10^3µl IPF High % IPF CASE STUDY 59 YEAR OLD FEMALE WITH STAGE IV METASTATIC BREAST CANCER CBC Cycle 1 Cycle 3 Cycle 3 Day 8 Cycle 4 Units Normal Range WBC Low 2.1 Low 2.6 Low X10^3µl 4-11 RBC Low 2.99 Low 3.41 Low X10^6µl HgB Low 10.6 Low 10.0 Low g/dl HCT Low 31.1 Low 30.0 Low % PLT Low 17 Low 119 Low X10^3µl IPF High % Value of IPF Relevant data that may contribute to treatment decisions Part of CBC, using the same lavender tube Results can be obtained quickly without additional drain on resources Minimal cost and no discomfort compared to invasive diagnostic testing The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Cancer and Hematology of Western Michigan. The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Cancer and Hematology of Western Michigan. IMMATURE PLATELET FRACTION TO ASSESS BONE MARROW RECOVERY RETICULOCYTE CHANNEL IRF Study Objective How well can IPF help the clinician predict bone marrow recovery following peripheral blood HPC transplantation? (N=50) A persistently low IPF in this setting would suggest failure of thrombopoietic recovery. RBC LFR MFR RET HFR IRF PLT Zucker, M., et al. Immature Platelet Fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Laboratory Hematology :
10 3/31/2017 RETICULOCYTES IRON DEFICIENCY PREVALENCE IN INFANTS AND TODDLERS Adverse consequences in pediatric patients: Increased lead absorption Impaired immunity Anemia Impaired neurocognitive development Ret%= Quantity IRF=Rate of Production Ret-He=Quality of Retics % of infants and toddlers in the US have iron deficiency anemia; 10% have iron deficiency without anemia. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. CONDITIONS AFFECTING TEST RESULTS Test Serum Iron Falsely Increased Results CASE STUDY : ANEMIA IN PREGNANCY Falsely Decreased Results Infection/Inflammation Sample late in the day Meal iron intake Supplement iron intake Hemolysis Diurnal variation Transferrin Saturation Oral contraceptive Infection/Inflammation Serum Ferritin Infection/Inflammation Hyperthyroidism Aging Liver disease (HCV) Malignancy Alcohol consumption Oral contraceptives Vitamin C deficiency Hypothyroidism Exercise Lab WBC g/dl RBC x 106/µl Hgb Normal Range ng/ml Hct % MCV mcg/dl MCH pg MCHC g/dl RDW mcg/dl Patient History/Presentation: Pregnant female presents to physician for a scheduled evaluation. Routine CBC is within normal limits. The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Dr. Pambrum, Dalhousie University Hospital, Nova Scotia. CASE STUDY : ANEMIA IN PREGNANCY Lab MCH 28.3 MCHC g/dl RDW mcg/dl Reticuloytes (%) 1.54 H % Reticulocytes (#) 64.8 H x106/µl IRF % RET-He 20.6L pg/cell SMEAR REVIEW & FERRITIN RESULTS Normal Range pg Smear Review no evidence if IDA Ferritin Results confirms diagnosis of IDA Reticulocyte panel provides additional insight regarding diagnosis. Ferritin 6.8 L g/dl Diagnosis: Iron deficiency anemia secondary to pregnancy (based upon reticulocyte panel data) The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Dr. Pambrum, Dalhousie University Hospital, Nova Scotia. The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Dr. Pambrum, Dalhousie University Hospital, Nova Scotia. 10
11 3/31/2017 CASE STUDY : INFANT W ITH LETHARGY Lab CASE STUDY : INFANT W ITH LETHARGY Normal Range Lab RBC x 106/µl MCH 17.5 L HgB 7.0 L ng/ml MCHC 295 L Normal Range g/dl HCT 23.7 L % RDW 19.3 H mcg/dl MCV 59.1 L pg mcg/dL Reticulocyte (%) 0.68 L % MCH 17.5 L pg Reticulocyte (#) 27.3 L x 106/µl MCHC 295 L g/dl IRF 4.8L % RDW 19.3 H % RET-He 11.9 L pg/cell Reticulocyte panel provided additional data that enhanced plan of care Patient History/Presentation: 5 month old presents to ER with lethargy and decreased appetite Diagnosis: Severe iron deficiency anemia secondary to poor intake and nutrition Treatment Plan: Started on oral iron therapy and instructed to see pediatrician in 7 day for repeat labs and evaluation The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Dr. Pambrum, Dalhousie University Hospital, Nova Scotia. The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Dr. Pambrum, Dalhousie University Hospital, Nova Scotia. CASE STUDY : INFANT W ITH LETHARGY Lab Day 7 Normal Range CASE STUDY : INFANT W ITH LETHARGY Lab Day 7 RBC x 106/µl MCH 17.5 L 18.2 L pg HgB 7.0 L 7.20 L ng/ml HgB 7.0 L 7.20 L ng/ml HCT 23.7 L 24.1 L % HCT 23.7 L 24.1 L MCV 59.1 L 60.9 L mcg/dl Reticulocyte (%) 0.68 L % MCH 17.5 L 18.2 L pg Reticulocyte (#) 27.3 L x 106/µl MCHC 295 L 299 L g/dl IRF 4.8 L 45.5 H % RDW 19.3 H 23.3 H mcg/dl RET-He 11.9 L 24.6 L pg/cell Reticulocyte (%) 0.68 L % Is therapy working? Caregiver noncompliance vs non-responder to therapy What is the next step? Admit to hospital for intravenous iron therapy Recommend gastrointestinal consult to rule out an malabsorption issue The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Dr. Pambrum, Dalhousie University Hospital, Nova Scotia. CLINICAL APPLICATIONS OF RETICULOCYTE HEMOGLOBIN Wellness Pediatrics - Iron deficiency and Iron Deficiency Anemia Prevention Surgical patients pre and post surgical assessments Chronic Disease Management Normal Range % Reticulocyte panel provided clinically significant data that enhanced care Is therapy working? Yes - RET-He shows an appropriate increase What is the next step? Continue on oral iron therapy with routine follow up The views expressed in the following slide are those of the author and their healthcare facility. Results of case studies are not predictive of other cases and results may vary. With permission from Dr. Pambrum, Dalhousie University Hospital, Nova Scotia. CLINICAL VALUE OF RET-He PARAMETER Value of RET-He May show iron was absorbed and treatment was effective Well-defined lower range cut off provides accurate treatment target Stable parameter that is not affected by inflammation/infection Less expensive than traditional iron tests without extra resources needed Quick and clinically relevant data for iron treatment decisions End Stage Renal Disease - anemia management Monitoring response to therapy with ESA and/or iron Cancer- anemia status 11
12 PERFORMANCE OF RET-He IN CANCER Patient Screening With RET-He N=200 Reduced Iron Studies by 80% RET-He <32 pg And Hgb <11 g/dl NPV 98.5% Rapid rule out of iron deficiency anemia Reduced unnecessary testing Cost savings for laboratory and health care system Body Fluids..Oh no!!! Peerschke, E., et al. Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer. AJCP : WHAT TYPES OF BODY FLUIDS ARE APPROVED? THE CHALLENGES HF-BF Body fluid mode (target species) Cerebrospinal fluid (CSF) Types of fluids, collection methods, clotted, viscous specimens Types of cells challenges techs of every skill level. MN Pleural fluid Peritoneal fluid MO-BF LY-BF NE-BF PMN EO-BF Synovial fluid WDF Scattergram AND MORE CHALLENGES SO WHY AUTOMATE? Small Sample Volume Better Precision Fast TAT Reportable Range Easy to Perform Safer Only 88uL Aspirated Precision within 10-30% depending on the result Capable of processing 40 specimens per hour RBC as low as x 106 WBC as low as x 103 No Pre-dilution or Analyzer Prep required Closed Sample Handling 12
13 WHAT ARE YOU GETTING IN THE BODY FLUID COUNT WBC Count RBC Count 2-part Differential TNC Total Nucleated Cells THE BODY FLUID SCATTERPLOT TNBC all highly fluorescent body fluid cells. Mesothelial Cells, Macrophages, Atypical and malignant lining cells. Mononuclear area part of the WBCBF area small mononuclear cells lymphocytes and monocytes Polymorphonuclear area part of the WBCBF area all segmented cells, Neutrophils and eosinophils WBCBF The total of the PMN and MN area SUGGESTIONS FOR TOUGH SAMPLES MORE SUGGESTIONS If there are clots in the specimen, take them out. You can still give an approximate count and make a smear Synovial fluids are often too viscous to be properly aspirated. Add Hylauronidase (~5mg to a mL aliquot) That s not what I was taught? What s really important is the cell type! SO WHAT IS IMPORTANT TO KNOW? Background counts Scatterplots Flags WBC BG Counts acceptable </=.001 RBC BG Counts acceptable </=.003 WBC-BF counts that exceed 1.000X 10^3 and/or RBC-BF counts that exceed 1.000X 10^6 will automatically activate an auto rinse after the count is reported. This eliminates carry-over of the next specimen 13
14 WBC ABNORMAL SCATTERGRAM This BG count failed for WBC due to the previous fluid that had a high cellular count When there is abnormal or incomplete clustering in the WDF Channel When the ration of high fluorescent cells is increased per 100 WBCs Signals Manual review **NOTE: This flag should be used if the customer is reporting TNC and the two part differential. The flag will warn the customer of the presence of high fluorescent BF cells such as mesothelial and tumor cells. Manual review would be suggested. There are no Sysmex suggested values for this setting The type of cell is more important than the quantity of cells. WHAT ARE WE REALLY AFRAID OF? Mesothelial Malignant HOW TO TELL THEM APART Mesothelial Individual Uniform Flat clusters N/C ratio low Smooth nuclear membrane Minimal vacuolization Round/oval nuclei Malignant Cannibalism Bizarre Ball-like clusters N/C ratio high Irregular nuclear membrane Nuclear clefting/molding Dramatic vacuolization Did you know.? Mesothelial Cells are only found in Serous fluids? 14
15 NORMAL BODY FLUID HIGH BODY FLUID COUNT BF CASE STUDY : BACTERIAL MENINGITIS A 59 year old male with a craniotomy presented with subcutaneous leakage of CSF and it was determined that the patient had bacterial meningitis. BACTERIAL MENINGITIS : CSF SAMPLE BF CASE STUDY : LUNG CANCER PATIENT A 60 year old was receiving treatment for lung cancer when an accumulated amount of pleural fluid was noticed in the right lung. 15
16 LUNG CANCER : PLEURAL FLUID You can find more interesting Case Studies on My Sysmex! Thank You 16
XN-SERIES. XN Technology and Case Studies
XN Technology and Case Studies Karen Hoffman MT(ASCP) Clinical Applications Specialist OBJECTIVES Explain how scattergrams and histogram pictures can provide great insight into abnormal hematology samples
More informationXN-SERIES. Hematology Case Studies: Every Picture Tells a Story
Hematology Case Studies: Every Picture Tells a Story Jill Crist MT(ASCP)Field Product Specialist OBJECTIVES Explain how scattergrams and histogram pictures can provide great insight into abnormal hematology
More information9/23/2018. Hematology Case Studies Jason Anderson, MPH, MT(ASCP) Field Product Specialist OBJECTIVES FLUORESCENT FLOW CYTOMETRY
Hematology Case Studies Jason Anderson, MPH, MT(ASCP) Field Product Specialist OBJECTIVES Discuss how scattergram and histogram pictures can provide insight into abnormal hematology samples Utilize case
More information5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN
DISCUSSION POINTS Importance of hematological immature cell indices Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN Investigate the evidence for clinical utility:
More information10/30/2015. XN Case Studies: Every Picture Tells a Story
XN Case Studies: Every Picture Tells a Story Jill Crist MT(ASCP)Field Product Specialist OBJECTIVES Explain how scattergrams and histogram pictures can provide great insight into abnormal hematology samples
More informationCASE STUDIES PERIPHERAL BLOOD AND BODY FLUIDS
CASE STUDIES PERIPHERAL BLOOD AND BODY FLUIDS WHERE TO START anemias hemoglobinopathies new and old parameters uncommon things fluids.benign and malignant.yuk! really annoying stuff and maybe some entertainment
More informationLavender Top Management SUCCESS BEYOND FINANCES
Lavender Top Management Alfonso Ziccardi Ass.Lab.Operation Manager for AP/CP/Safety Officer New York Hospital Medical Center of Queens SUCCESS BEYOND FINANCES 1 . VISION Mission/ Vision To successfully
More informationLavender Top Management SUCCESS BEYOND FINANCES. Mission/ Vision
Lavender Top Management Alfonso Ziccardi Lab.Operation Manager for AP/CP/Safety Officer New York Hospital Medical Center of Queens SUCCESS BEYOND FINANCES Mission/ Vision. VISION To successfully develop
More information10/15/2015. Clinical Utility of Immature Cell Indices DISCUSSION POINTS HEALTHCARE REFORM PAYMENT MODEL EXPERIMENTS
Clinical Utility of Immature Cell Indices Leveraging Technology to Help Manage Anemia and Blood Utilization donnellyj@sysmex.com 2015 Sysmex America, Inc. All rights reserved. For Clinical Support Team
More informationFull Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa
Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa The Role of the FBC in clinical decision making History Examination Investigations Decision 70% FBC Laboratory
More informationXN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016
XN series Case interpretation Gebruikersdag Vlaanderen- 6 oktober 2016 Fluorescence flow cytometry RET channel PLT-F channel WDF channel WPC channel WNR channel Case 1 Case 1: Initial measurement Patient
More informationCombining. and New Diagnostic. to Help Clinicians Achieve. Patient Outcomes at. per Healthcare Encounter
Combining and New Diagnostic to Help Clinicians Achieve Patient Outcomes at per Healthcare Encounter Holly McDaniel, MD hmcdaniel@clinpath.com Holly.mcdaniel@bannerhealth.com Holly McDaniel, MD AP/CP and
More informationEvidence-Based Hematological Solutions
Evidence-Based Hematological Solutions Beyond the Routine CBC Objectives Describe novel hematology parameters and their derivation. Investigate the evidence for their clinical utility. Discuss how new
More informationInterpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture
Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture Barbara L. Burch, MHA MT (ASCP) Laboratory Manager New York University Clinical Cancer Center Disclosure Ms Burch
More informationHematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist
Hematology 101 Cindy Rogers, MT(ASCP) Diagnostics System Specialist More Acronyms...» CBC» RBC» HGB» HCT» WBC» MPV» PLT» RDW» DIFF» H&H» Complete Blood Count» Red Blood Cell» Hemoglobin» Hematocrit» White
More informationCollect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.
Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,
More informationA Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter
A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter Is cell morphology important? AML M7 CLL CD5 CD19 NHL
More informationINFECTION/ INFLAMMATION
HAEMATOLOGY OCTOBER 2017* WHITE PAPER INFECTION/ INFLAMMATION Novel haematological parameters for rapidly monitoring the immune system response Patients with inflammatory disease are common on hospital
More informationNEW HEMATOLOGY PARAMETERS
NEW HEMATOLOGY PARAMETERS CASE STUDIES and IMPLEMENTATION WHAT WE WILL COVER new parameters Ret-He, IPF (and some not so new parameters) - anemias - hemoglobinopathies - problem platelets - uncommon things
More informationSysmex Journal International Vol.9 No.2 (1999)
Sysmex Journal International Vol.9 No. (999) Evaluation and Clinical Usefulness of the Automated Hematology Analyzer, Sysmex XE- TM Kazuto TSURUDA, Tomohiro TSUJI, Tetsuya USUI, Sachiko KITAJIMA, Atsuko
More informationLEANING Away Waste and Improving Patient Care with Advances in Hematology
LEANING Away Waste and Improving Patient Care with Advances in Hematology Selke Mantie, MLS (ASCP), CLS (CSMLS), SSGBC Disclosure I am receiving an honorarium from Sysmex for today s presentation Objectives
More information3. Blood Cell Histograms:
LECTURE MODULE 6c: ELECTRONIC CELL COUNTING PART III 3. Blood Cell Histograms: a. The Coulter cell counters today provides size distributions of the cellular content: 1) volume given in µm 3 or fl vs relative
More informationHematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD
Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,
More informationIt s Easier Than you Think How to Implement the Advanced Clinical Parameters
It s Easier Than you Think How to Implement the Advanced Clinical Parameters Implementation of our New Hematology Platform ( 9 HST Lines - 9 Facilities - 9 Month) Outline The Organization Banner Health
More informationThe Complete Blood Count
The Complete Blood Count (Cartesian Thinking at Its Best) A SEM Image of Normal Human Blood Laurie Larsson February 22, 2010 Anatomy and Philology II Dr. Danil Hammoudi Introduction A complete blood count
More informationBeyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for
More informationKathleen Finnegan MS MT(ASCP)SHCM
Kathleen Finnegan MS MT(ASCP)SHCM Discuss the history of hematology automation and digital differentials. Discuss the HemoFAXS Hematology Analysis System by Tissue Gnostics. Review automated microscopy
More informationPlease contact Customer Service with any questions. Ph: option 5
Sarasota Memorial Laboratory Services is pleased to announce that we are now performing the following testing in house: Immature Platelet Fraction (IPF) The Immature Platelet Fraction (IPF) is used to
More informationBrief Communication Diagnostic Hematology
Brief Communication Diagnostic Hematology Ann Lab Med 2016;36:244-249 http://dx.doi.org/10.3343/alm.2016.36.3.244 ISSN 2234-3806 eissn 2234-3814 Establishment of Age- and Gender-Specific Reference Ranges
More informationInterpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired
Interpreting the CBC Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired The CBC 3 Cell Lines RBCs WBCs Platelets Assess general health Make
More informationCELL-DYN Strength in Technology, Proven Reliability. Optical WBC Technology. Patented M.A.P.S.S. Differential. Multiple Technologies
CELL-DYN 3700 Strength in Technology, Proven Reliability Optical WBC Technology Patented M.A.P.S.S. Differential Multiple Technologies CELL-DYN 3700 Multiple Technologies One Superior Result Multiple Technologies
More information8/28/2015. ACP Toolbox SYSMEX CLINICAL SUPPORT TEAM SYSMEX CUSTOMER RESOURCE CENTER. Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI
ACP Toolbox Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI SYSMEX CLINICAL SUPPORT TEAM Available to provide education and resources: Tailored presentations Customer Resource Center tools Current
More informationHematopathology Case Study
www.medfusionservices.com Hematopathology Case Study CV3515-14 JUNE Clinical Presentation: Clinical Information: A 42 year old male with history of chronic myelogenous leukemia (CML) presents with an elevated
More informationof s and s Disclosure
The s of s and s Successfully implement the Advanced Clinical Parameters to benefit the patient, the lab and the Accountable Care Organization Model Disclosure Honorarium from Sysmex for this lecture 1
More informationAutomated Hematology Analyzer. Differentiate with the XT-4000i
XT-4000i Automated Hematology Analyzer Differentiate with the XT-4000i Advanced Technology Solutions to Meet Your Lab s Needs Even with these challenges, the need for hematology testing has remained steady
More informationADx Bone Marrow Report. Patient Information Referring Physician Specimen Information
ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS
More informationComplete Blood Count (CBC) Assist.Prof. Filiz BAKAR ATEŞ
Complete Blood Count (CBC) Assist.Prof. Filiz BAKAR ATEŞ The complete blood count (CBC) is one of the most common blood test used. It analyzes the three major types of cells in blood 1. red blood cells,
More informationMyeloproliferative Disorders - D Savage - 9 Jan 2002
Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2
More informationMECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood
More informationFEARLESS FLUIDS WHAT WE LL COVER. DEPENDS ON WHAT YOU DREAD THE MOST CSF, SEROUS, SYNOVIAL MANUAL CELL COUNTS A LITTLE, VERY LITTLE
FEARLESS FLUIDS DEPENDS ON WHAT YOU DREAD THE MOST YUCKY CELL COUNTS SCARY CELLS WHAT WE LL COVER. CSF, SEROUS, SYNOVIAL MANUAL CELL COUNTS A LITTLE, VERY LITTLE AUTOMATED CELL COUNTS WHAT S IMPORTANT
More informationCustomer Information Literature List Platelets
Customer Information Literature List Platelets Date: August 2015 Subject: Literature List Platelets Issued by: Scientific Customer Services Number: 150803 Note: Whether references are given in British
More informationEDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION
EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click
More informationHEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE
Log Out Help current login :lcytryn@montefiore.org HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE Lawrence Cytryn, M.D. - Course Director 1998 Edward Burns, M.D. Images used by permission within AECOM
More informationUtilizing Sysmex RET He to Evaluate Anemia in Cancer Patients
Utilizing Sysmex RET He to Evaluate Anemia in Cancer Patients Ellinor I. Peerschke, Ph.D., F.A.H.A. Vice Chair, Laboratory Medicine Chief, Hematology & Coagulation Laboratory Services Memorial Sloan Kettering
More informationTaking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss
Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside Blood Cell Abnormalities Abnormalities
More informationHAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore
HAEMATOLOGICAL EVALUATION OF ANEMIA Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore Learning Objectives Laboratory tests for the evaluation of anemia
More informationNORMAL LABORATORY VALUES FOR CHILDREN
Pediatric Drug Lookup Normal Laboratory Values for NORMAL LABORATORY VALUES FOR CHILDREN CHEMISTRY Normal Values Albumin 0-1 y 2.0-4.0 g/dl 1 y to adult 3.5-5.5 g/dl Ammonia Newborns 90-150 mcg/dl 40-120
More information2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228
2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07
More informationCELL-DYN 3700 Strength in Technology, Proven Reliability
CELL-DYN 3700 Strength in Technology, Proven Reliability Optical WBC Technology Patented MAPSS Differential Multiple Technologies CELL-DYN 3700 Multiple Technologies One Superior Result Multiple Technologies
More informationThe Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)
The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,
More informationCustomer Information Literature List White Blood Cells
Customer Information Literature List White Blood Cells Date: September 2015 Subject: Literature List White Blood Cells Issued by: Scientific Customer Services Number: 150901 Note: Whether references are
More informationFEAR. DEPENDS ON WHAT YOU DREAD THE MOST
FEARLESS FLUIDS FEAR. DEPENDS ON WHAT YOU DREAD THE MOST YUCKY CELL COUNTS SCARY CELLS WHAT WE LL COVER. CSF, SEROUS, SYNOVIAL MANUAL CELL COUNTS A LITTLE, VERY LITTLE AUTOMATED CELL COUNTS AMR, CRR, METHOD
More informationGroup of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and
Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and / or peripheral blood Classified based on cell type
More informationGuide to the 1-3 Minute Blood Film Microscopic Review: Why and How?
Guide to the 1-3 Minute Blood Film Microscopic Review: Why and How? Dennis B. DeNicola, DVM, PhD, DACVP Chief Veterinary Educator IDEXX Laboratories, Inc. Westbrook, ME USA Adjunct Professor of Veterinary
More informationThe importance of thrombocytopenia and its causes
SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NO 4 2017 SEED HAEMATOLOGY The importance of thrombocytopenia and its causes Key words: Thrombocytopenia, thrombocytopenic, low levels of platelets What is
More informationNationwide Children s Hospital
Implementing IPF and RET He: Clinical Applications in a Pediatric Setting Gretchen Dennis MT(ASCP) cm, MLS(ASCP) Technical Specialist Routine Hematology Nationwide Children s Hospital 1 We have been growing!
More informationClinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock
Learning Objectives At the completion of this program, the participants will be able to: 1. Identify the components of the CBC and Differential and their clinical implications. 2. Identify normal pediatric
More informationRapid Laboratories In House Tests
Electrolytes CL CL (CHLORIDE) Electrolytes CO2 CO2 (BICARBONATE) Electrolytes K K (POTASSIUM) Electrolytes NA NA (SODIUM) Basic Metabolic Panel (BMP) GLU GLU (GLUCOSE) Basic Metabolic Panel (BMP) CA CA
More informationAnemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017
Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.
More informationDeconstructing the CBC
Deconstructing the CBC Dr. Ann M. Wexler Solano Hematology Oncology September 10, 2017 What Are the Major Components of Blood? Red Blood Cells (also called erythrocytes) White Blood Cells (also called
More informationCHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009
LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of
More informationHematopathology Case Study
Hematopathology Case Study AMP Outreach Course 2009 AMP Annual Meeting John Greg Howe Ph.D. Department of Laboratory Medicine Yale University School of Medicine November 19, 2009 HISTORY Case History An
More informationWBCs Disorders 1. Dr. Nabila Hamdi MD, PhD
WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features
More informationAdvanced parameters offer faster, surer guidance to cancer care
Advanced parameters offer faster, surer guidance to cancer care captodayonline.com /advanced-parameters-offer-faster-surer-guidance-cancer-care/ Anne Paxton 9/18/2017 September 2017 After a career spent
More informationEvaluation of the Diagnostic Performance of the Sysmex XT-2000i Automated Hematology Analyzer in the Detection of Immature Granulocytes
Evaluation of the Diagnostic Performance of the Sysmex XT-2000i Automated Hematology Analyzer in the Detection of Immature Granulocytes A. M. CENCI *1, M. MACONI *2, and B. CASOLARI *1 *1 Laboratory of
More informationProper Slide Preparation
Hematology Essentials: A Foundation for WBC Review Using Case Studies Christine Hinz, MS, MLS(ASCP) CM Proper Slide Preparation smooth, homogenous film 1/2 to 3/4 the slide length straight feather edge
More informationSysmex Journal International Vol.26 No.1 (2016)
Sysmex Journal International Vol.26 No.1 (216) Performance Evaluation of the XN-55 Automated Hematology Analyzer Body Fluid Mode Considerations for Operational Conditions for Cell Counting with Cerebrospinal
More informationMay is Better Sleep Month
Produced by Eastern Iowa Sleep Center A Partnership: UnityPoint-St.Luke s Mercy Medical Center Physicians Clinic of Iowa MAY 2015 VOLUME 4 ISSUE 2 Eastern Iowa Sleep Center May is Better Sleep Month Mother
More informationGetting Beyond the Flags: Quantitative assessment of immature granulocyte (IG) populations may improve the assessment of sepsis and inflammation.
Getting Beyond the Flags: Quantitative assessment of immature granulocyte (IG) populations may improve the assessment of sepsis and inflammation. Sysmex America White Paper One Nelson C. White Parkway,
More informationBlutbild 2012: Automatisiert oder manuell? Georg Stüssi Servizio di Ematologia Istituto Oncologico della Svizzera Italiana
Blutbild 2012: Automatisiert oder manuell? Georg Stüssi Servizio di Ematologia Istituto Oncologico della Svizzera Italiana IS THERE STILL A ROLE FOR THE MANUAL BLOOD COUNT? Indication for examination
More informationDR SUDHIR MEHTA MD,MNAMS,FICP. Senior Professor & Head Medical Unit SMS Medical College & Hospital Jaipur
DR SUDHIR MEHTA MD,MNAMS,FICP Senior Professor & Head Medical Unit SMS Medical College & Hospital Jaipur s.smehta@hotmail.com CBC..What is the Utility of performing this basic Hematology Test? 10/31/2010
More informationI. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals
I. Definitions II. III. Red blood cell life cycle Iron metabolism IV. Causes of anemia A. Kinetic approach 1. decreased production 2. increased destruction 3. blood loss B. Morphologic approach 1. normocytic
More informationCbc with differential
Cbc with differential Other tests might be necessary based on the results of the differential test and follow-up tests. Your doctor has many ways of determining and treating causes of abnormal blood cell
More informationDisclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016
Disclosures/COI Cases in Hematopathology Vamsi Kota Assistant Professor Department of Hematology & Medical Oncology Leukemia/BMT I have no disclosures or conflicts of interest regarding this presentation.
More informationDoes Morphology Matter in 2017
Does Morphology Matter in 2017 ISLH May 2017 Kathryn Foucar Distinguished Professor Emerita kfoucar@salud.unm.edu Objectives Recognize unique RBC and WBC abnormalities in non-neoplastic disorders Learn
More informationNEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016
NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016 Results from this proficiency test event are available at: http://www.wadsworth.org/regulatory/clep/pt/summaries SLIDE
More informationYear 2003 Paper two: Questions supplied by Tricia
QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]
More informationUse of the XE-2100 in a Patient with Cold Auto-immune Hemolytic Anemia
Use of the XE-21 in a Patient with Cold Auto-immune Hemolytic Anemia Gudrun STAMMINGER and Lothar BEIER Klinikum Chemnitz ggmbh, Institut für Laboratoriumsmedizin, Flemmingstraße 2, Chemnitz, Germany.
More informationQUESTIONS OF HEMATOLOGY AND THEIR ANSWERS
QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS WHAT IS TRUE AND WHAT IS FALSE? Questions 1 Iron deficiency anemia a) Is usually associated with a raised MCV. b) The MCH is usually low. c) Is most commonly due
More informationFaculty of Medicine Dr. Tariq Aladily
Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin
More informationBlood Cell Identification Graded
Blood Cell Identification Graded Case History The patient was a five-day-old girl with an elevated unconjugated bilirubin and a weakly positive direct antiglobulin test (DAT). Her CBC showed: WBC = 11.0
More informationContinuing Education Questions
FOCUS: INTERPRETING THE COMPLETE BLOOD COUNT Continuing Education Questions SUMMER 2017 1. A methodical approach to CBC interpretation that is aimed at medical laboratory professionals differs from one
More informationMyeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP
Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS
More informationLeukocytosis - Some Learning Points
Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful
More informationBlood Cell Identification Graded
BCP-21 Blood Cell Identification Graded Case History The patient is a 37-year-old female with a history of multiple sickle cell crises. She now presents with avascular necrosis of the left hip. Laboratory
More information74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow
74y old Female with chronic elevation of Platelet count August 18, 2005 Faizi Ali, MD Hematopathology Fellow Clinical History Patient is a 74y old otherwise healthy Caucasian female with no major complaint
More informationThe LaboratoryMatters
Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. Complete Blood Count This issue highlights: CBC, while ubiquitous, is an excellent diagnostic
More informationCOMPANY OR UNIVERSITY
CONTRIBUTOR NAME Daniel Heinrich, DVM CONTRIBUTOR EMAIL dheinric@umn.edu COAUTHORS Jed Overmann, DVM, DACVP; Davis Seelig DVM, PhD, DACVP & Matthew Sturos, DVM COMPANY OR UNIVERSITY University of Minnesota
More informationDisorders of Blood Cells & Blood Coagulation
Disorders of Blood Cells & Blood Coagulation HIHIM 409 WBC count RBC count WBC differential Hemoglobin (HGB) Hematocrit (HCT) % of volume occupied by RBCs CBC Red cell indices Mean cell volume (MCV) average
More informationBODY FLUID ANALYSIS. Synovial Fluid. Synovial Fluid Classification. CLS 426 Urinalysis and Body Fluid Analysis Body Fluid Lecture Session 1
BODY FLUID ANALYSIS Synovial Fluid Serous fluids the 3 P s Peritoneal Pleural Pericardial Cerebrospinal Fluid Karen Keller, MT(ASCP), SH Synovial Fluid Lubricant and sole nutrient source of joint. Normal
More informationClinician Blood Panel Results
Page 1 of 8 Blood Panel - Markers Out of Range and Patterns (Pattern: proprietary formula using one or more Blood Markers) Blood Panel: Check for Markers that are out of Lab Range ***NOTE*** Only one supplement
More informationClinical use of flow cytometry
Clinical use of flow cytometry Diagnosis of leukemia Combined use of intracellular staining and a cell surface marker Detection of stem cells CD34+ stem cells Monitoring of stem cell count following
More informationThe Evolving Role of Reticulated Platelets
The Evolving Role of Kyle Riding, PhD, MLS(ASCP) CM University of Central Florida Session Objectives Platelets Recall the process involved in megakaryopoiesis and thrombocytopoiesis Explain the various
More informationMyelodysplastic syndrome (MDS) & Myeloproliferative neoplasms
Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)
More informationDifferential Blood Smear H3
Verein für Association pour le Associazione per il medizinische Qualitätskontrolle contrôle de qualité médical controllo di qualità medico Report Differential Blood Smear H3 MQ 2015-4 MQ, Institut für
More informationOrdering Physician CLIENT,CLIENT. Collected REVISED REPORT
HPWET Hematopathology Consultation, MML Embed Client Hematopathology Consult REVISED INAL DIAGNOSIS Interpretation Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular
More informationASPEN MOUNTAIN MEDICAL CENTER. Lab Health Fair
ASPEN MOUNTAIN MEDICAL CENTER Lab Health Fair GENERAL HEALTH PANEL: CMP CMP The Comprehensive Metabolic Panel is used as a broad screening tool to evaluate organ function and check for conditions such
More informationThe Value-Driven Laboratory. The Role of the Immature Platelet Fraction (IPF) in the Differential Diagnosis of Thrombocytopenia
The Value-Driven Laboratory The Role of the Immature Platelet Fraction (IPF) in the Differential Diagnosis of Thrombocytopenia Sysmex America White Paper 577 Aptakisic Road Lincolnshire, IL 669 USA www.sysmex.com
More informationClinician Blood Panel Results
Page 1 of 7 Blood Panel - Markers Out of Range and Patterns (Pattern: proprietary formula using one or more Blood Markers) Blood Panel: Check for Markers that are out of Lab Range ***NOTE*** Only one supplement
More information